Terlipressin Alone Versus the Standard Therapy With Catecholamines for Hepatic Patients With Septic Shock- Prospective Single Center Randomized Controlled Study.
Clinical trial NCT03608514 · UNKNOWN
Trial details
- NCT number
- NCT03608514
- Sponsor
- National Hepatology & Tropical Medicine Research Institute
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-01
- Primary completion
- 2020-07-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.